juni 26, 2020
Lead ‘OncoMimics’ candidate EO2401 planned to start first clinical trials for Glioblastoma and Adrenal Tumors during mid-2020 Paris, France and Cambridge, MA, USA – June 25, 2020 ENTEROME SA, a clinical-stage biopharmaceutical company leveraging its unique knowledge  of the microbiome-immunoinflammation axis to develop next-generation therapeutics, today announces a new financing totaling €46.3 million ($52.6million) to...


Lundbeckfonden Ventures investerer i antidot mod blodfortyndere
8. juli 2020
Erfaren hjerneforsker i spidsen for The Brain Prize
30. juni 2020
Otte lovende yngre forskere får Lundbeckfonden fellowship
16. juni 2020


Lundbeckfonden Ventures

Lundbeckfonden Emerge